← Case Studies
Zeroharm
Project Dates: January 2023
Creative Testing Scaled India's Leading Nutraceutical Brand by Optimizing Ad Spend and Driving High-Performance Growth Through Data
₹1.27Cr → ₹7.17Cr
Monthly Revenue Growth
464%
Revenue Growth (1 quarter)
5+
Top Selling SKUs Scaled (vs 1 dominant before)
₹7.17Cr
Q2 2024 - Quarterly Revenue
Context
Zeroharm, India’s leading nutraceutical brand, needed a data-driven creative strategy to identify high-potential winning products across a wide catalogue, expand into new product lines, and build monthly recurring revenue at scale.
Objectives
- Identify high-potential winning products from the catalogue
- Expand product catalog reach through performance media
- Accelerate Monthly Recurring Revenue (MRR)
What we did
- The Planning – Daily creative iteration pipeline flowing into catalog-wide scaling
- The Process – Direct assessment fed into a structured brief sheet, then to designers
- The Quality Check – Internal and management oversight, client feedback integration, and agile revision cycles
- Applied the Creative Intelligence Framework across all activity:
- Theme-Specific Product Analysis
- Audience Awareness Segmentation
- ROAS-Focused Scaling
- Resonance Spend Tracking